WSJ Your Money Briefing
Making Sense of Weight-Loss Drugs’ Cost and Coverage
Wed, 04 Jun
From Default Workspace • No contributors
Description
GLP-1s like Ozempic and Wegovy are no longer in short supply, yet they still can cost more than $1,000 a month out of pocket. Wall Street Journal contributor Cheryl Winokur Munk joins host Callum Borchers to dig into why some people pay much more for weight-loss drugs than others. Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster